Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users

Trends Psychiatry Psychother. 2017 Oct-Dec;39(4):239-246. doi: 10.1590/2237-6089-2016-0081. Epub 2017 Nov 13.

Abstract

Background: This study examined drug use patterns and psychiatric symptoms of anxiety and depression among young Brazilian sexual minority ecstasy and LSD users and compared findings with those reported for their heterosexual peers.

Method: This cross-sectional study employed targeted sampling and ethnographic mapping approaches via face-to-face interviews conducted at bars and electronic music festivals using an adapted, semi-structured version of the Global Appraisal of Individual Needs questionnaire. The sample comprised 240 male and female young adults who had used ecstasy and/or LSD in the 90 days prior to the interview and who were not on treatment for alcohol and drug abuse.

Results: Of the 240 subjects enrolled (mean age: 22.9±4.5 years), 28.7% were gay or bisexuals. Multivariate regression analysis showed that the prevalence of depression symptoms in the past 12 months in the sexual minority group was 37% higher than among heterosexuals (prevalence ratio [PR]=1.79; 95% confidence interval [95%CI] 1.03-3.11; p=0.037).

Conclusion: Strategies should be developed to assess and address individual needs and treatment approaches should be tailored to address depressive symptoms in young, sexual minority club drug users.

Publication types

  • Observational Study

MeSH terms

  • Anxiety / ethnology*
  • Brazil / epidemiology
  • Cross-Sectional Studies
  • Depression / ethnology*
  • Female
  • Heterosexuality / psychology
  • Humans
  • Lysergic Acid Diethylamide / administration & dosage
  • Male
  • Multivariate Analysis
  • N-Methyl-3,4-methylenedioxyamphetamine / administration & dosage
  • Psychotropic Drugs / administration & dosage
  • Sexual and Gender Minorities / psychology*
  • Substance-Related Disorders / ethnology*
  • Substance-Related Disorders / psychology*
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Psychotropic Drugs
  • Lysergic Acid Diethylamide
  • N-Methyl-3,4-methylenedioxyamphetamine